This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov 1;8(12):668.

doi: 10.1038/nrcardio.2011.163.

Hypertension: First-in-class agent lowers BP

PMID: 22045044
DOI: 10.1038/nrcardio.2011.163

Comment

Hypertension: First-in-class agent lowers BP

Gregory B Lim. Nat Rev Cardiol. 2011.

. 2011 Nov 1;8(12):668.

doi: 10.1038/nrcardio.2011.163.

Author

PMID: 22045044
DOI: 10.1038/nrcardio.2011.163

No abstract available

PubMed Disclaimer

Comment on

Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.
Calhoun DA, White WB, Krum H, Guo W, Bermann G, Trapani A, Lefkowitz MP, Ménard J. Calhoun DA, et al. Circulation. 2011 Nov 1;124(18):1945-55. doi: 10.1161/CIRCULATIONAHA.111.029892. Epub 2011 Oct 10. Circulation. 2011. PMID: 21986283 Clinical Trial.

References

1. Circulation. 2011 Nov 1;124(18):1945-55 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.